201 related articles for article (PubMed ID: 35503582)
1. The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.
Kitzberger C; Spellerberg R; Morath V; Schwenk N; Schmohl KA; Schug C; Urnauer S; Tutter M; Eiber M; Schilling F; Weber WA; Ziegler S; Bartenstein P; Wagner E; Nelson PJ; Spitzweg C
EJNMMI Res; 2022 May; 12(1):25. PubMed ID: 35503582
[TBL] [Abstract][Full Text] [Related]
2. A new antiviral hypothesis and radioactive iodine therapy to other cancers, such as breast cancer, lung cancer, and glioblastoma multiforme (GBM)?
Czarnywojtek A; Gut P; Borowska M; Sawicka-Gutaj N; Caputa P; Kos-Kudła B; Ruchała M; Dworacka M
Endokrynol Pol; 2023; 74(6):. PubMed ID: 38159203
[TBL] [Abstract][Full Text] [Related]
3. The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment.
Spitzweg C; Nelson PJ; Wagner E; Bartenstein P; Weber WA; Schwaiger M; Morris JC
Endocr Relat Cancer; 2021 Sep; 28(10):T193-T213. PubMed ID: 34259647
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
Kitzberger C; Spellerberg R; Han Y; Schmohl KA; Stauss C; Zach C; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Clin Cancer Res; 2023 Mar; 29(5):930-942. PubMed ID: 36516189
[TBL] [Abstract][Full Text] [Related]
5. [
Jiang H; DeGrado TR
Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
[TBL] [Abstract][Full Text] [Related]
6. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
7. Selective sodium iodide symporter (
Spellerberg R; Benli-Hoppe T; Kitzberger C; Berger S; Schmohl KA; Schwenk N; Yen HY; Zach C; Schilling F; Weber WA; Kälin RE; Glass R; Nelson PJ; Wagner E; Spitzweg C
Mol Ther Oncolytics; 2021 Dec; 23():432-446. PubMed ID: 34853814
[TBL] [Abstract][Full Text] [Related]
8. Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma.
Spellerberg R; Benli-Hoppe T; Kitzberger C; Hageneier M; Schwenk N; Öztürk Ö; Steiger K; Multhoff G; Eiber M; Schilling F; Weber WA; Kälin RE; Glass R; Nelson PJ; Wagner E; Spitzweg C
Mol Ther Oncolytics; 2022 Dec; 27():272-287. PubMed ID: 36458201
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
Kitzberger C; Shehzad K; Morath V; Spellerberg R; Ranke J; Steiger K; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Mol Ther Oncolytics; 2023 Sep; 30():238-253. PubMed ID: 37701849
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of [
Niu M; Qin J; Wang L; He Y; Tian C; Chen Y; Huang P; Peng Z
Mol Imaging; 2022; 2022():2679260. PubMed ID: 35330799
[TBL] [Abstract][Full Text] [Related]
11. EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.
Urnauer S; Müller AM; Schug C; Schmohl KA; Tutter M; Schwenk N; Rödl W; Morys S; Ingrisch M; Bertram J; Bartenstein P; Clevert DA; Wagner E; Spitzweg C
Oncotarget; 2017 Nov; 8(54):92195-92208. PubMed ID: 29190908
[TBL] [Abstract][Full Text] [Related]
12. A Novel Approach for Image-Guided
Schug C; Gupta A; Urnauer S; Steiger K; Cheung PF; Neander C; Savvatakis K; Schmohl KA; Trajkovic-Arsic M; Schwenk N; Schwaiger M; Nelson PJ; Siveke JT; Spitzweg C
Mol Cancer Res; 2019 Jan; 17(1):310-320. PubMed ID: 30224540
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 18F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
Jiang H; Bansal A; Pandey MK; Peng KW; Suksanpaisan L; Russell SJ; DeGrado TR
J Nucl Med; 2016 Sep; 57(9):1454-9. PubMed ID: 27103021
[TBL] [Abstract][Full Text] [Related]
14. Tracking dendritic cell migration into lymph nodes by using a novel PET probe
Lee SB; Lee HW; Lee H; Jeon YH; Lee SW; Ahn BC; Lee J; Jeong SY
EJNMMI Res; 2017 Dec; 7(1):32. PubMed ID: 28378292
[TBL] [Abstract][Full Text] [Related]
15. High molar activity [
Soloviev D; Dzien P; Mackintosh A; Malviya G; Brown G; Lewis D
EJNMMI Radiopharm Chem; 2022 Dec; 7(1):32. PubMed ID: 36512196
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
[TBL] [Abstract][Full Text] [Related]
17. Safety, pharmacokinetics, metabolism and radiation dosimetry of
Jiang H; Schmit NR; Koenen AR; Bansal A; Pandey MK; Glynn RB; Kemp BJ; Delaney KL; Dispenzieri A; Bakkum-Gamez JN; Peng KW; Russell SJ; Gunderson TM; Lowe VJ; DeGrado TR
EJNMMI Res; 2017 Oct; 7(1):90. PubMed ID: 29080017
[TBL] [Abstract][Full Text] [Related]
18. Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (
Tutter M; Schug C; Schmohl KA; Urnauer S; Schwenk N; Petrini M; Lokerse WJM; Zach C; Ziegler S; Bartenstein P; Weber WA; Wagner E; Lindner LH; Nelson PJ; Spitzweg C
Theranostics; 2020; 10(10):4490-4506. PubMed ID: 32292510
[No Abstract] [Full Text] [Related]
19. Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.
Urnauer S; Klutz K; Grünwald GK; Morys S; Schwenk N; Zach C; Gildehaus FJ; Rödl W; Ogris M; Wagner E; Spitzweg C
J Gene Med; 2017 May; 19(5):. PubMed ID: 28423213
[TBL] [Abstract][Full Text] [Related]
20. Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter.
Lehmacher M; Stolzenburg A; Samnick S
Curr Cancer Drug Targets; 2020; 20(2):146-155. PubMed ID: 32056515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
